Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-08 Purchase | 2025-01-13 4:34 pm | Olema Pharmaceuticals Inc. | OLMA | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. Bain Capital Life Sciences Opportunities IV GP LLC Bain Capital Life Sciences Opportunities IV L.P. 10% Owner | 300,000 | $5.7579 | $1,727,370 | 11,300,000 (Indirect) | View |
| 2024-12-13 Purchase(A) | 2024-12-18 6:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-13 Sale(A) | 2024-12-18 6:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-17 Purchase | 2024-12-17 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-17 Sale | 2024-12-17 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) | View |
| 2024-12-10 Sale | 2024-12-11 7:56 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 16,393 | $9.0255 | $147,956 | 886,168 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:56 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 26,066 | $9.0124 | $234,916 | 766,010 (Indirect Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:54 pm | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 27,805 | $9.0076 | $250,456 | 115,509 (Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:53 pm | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 35,159 | $9.0077 | $316,703 | 543,549 (Direct) | View |
| 2024-12-10 Sale | 2024-12-11 7:52 pm | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 109,502 | $9.0077 | $986,365 | 241,662 (Direct) | View |
| 2024-06-04 Sale(A) | 2024-11-26 4:48 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2024-08-01 Sale | 2024-08-05 4:30 pm | Olema Pharmaceuticals Inc. | OLMA | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner | 2,400,000 | $14.91 | $35,796,000 | 783,118 (Indirect) | View |
| 2024-07-29 Sale | 2024-07-31 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $15.57 | $77,872 | 873,311 (Indirect Direct) | View |
| 2024-07-11 Sale | 2024-07-12 5:15 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $12.26 | $61,300 | 878,311 (Indirect Direct) | View |
| 2024-06-28 Sale | 2024-07-02 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.77 | $215,400 | 883,311 (Indirect Direct) | View |
| 2024-06-04 Sale | 2024-06-06 5:01 pm | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) | View |
| 2024-05-31 Sale | 2024-06-04 9:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $10.3 | $257,450 | 903,311 (Indirect Direct) | View |
| 2024-05-06 Sale | 2024-05-07 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 5,000 | $10.92 | $54,600 | 928,311 (Indirect Direct) | View |
| 2024-04-30 Sale | 2024-05-02 5:09 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 15,000 | $9.51 | $142,650 | 933,311 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-03-29 5:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 20,000 | $10.97 | $219,400 | 948,311 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-04 5:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $12.41 | $310,309 | 968,311 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-10 Option Award | 2025-01-14 6:38 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 420,000 | $0 | 6,854,528 (Direct) | View |
| 2025-01-10 Disposition | 2025-01-14 6:38 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 420,000 | $0 | 6,854,528 (Direct) | View |
| 2025-01-10 Other | 2025-01-13 4:34 pm | 2025-01-13 N/A | Olema Pharmaceuticals Inc. | OLMA | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. Bain Capital Life Sciences Opportunities IV GP LLC Bain Capital Life Sciences Opportunities IV L.P. 10% Owner | 3,500,000 | $0 | 11,300,000 (Indirect) | View |
Ownership | 2025-01-13 4:31 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. Bain Capital Life Sciences Opportunities IV GP LLC Bain Capital Life Sciences Opportunities IV L.P. 10% Owner | 0 | $0 | 12,013,216 (Indirect) | View |
| 2024-12-16 Exercise | 2024-12-17 7:29 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 14,000 | $4.87 | 242,349 (Direct) | View |
| 2024-12-16 Exercise | 2024-12-17 7:29 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 14,000 | $0 | 242,349 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:56 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 29,250 | $0 | 886,168 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:56 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 48,750 | $0 | 766,010 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:54 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 52,000 | $0 | 115,509 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:53 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 68,250 | $0 | 543,549 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 7:52 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 204,750 | $0 | 241,662 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-04 7:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 3,369,704 | $0 | 9,826,972 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-04 7:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2,465,178 | $9.0799 | 9,826,972 (Direct) | View |
| 2024-12-04 Disposition | 2024-12-04 7:55 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 3,369,704 | $0 | 9,826,972 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-18 06:00 am | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles Ch. Operating & Financial Off. | 25,000 | $7.02 | 672,458 (Direct) | View |
| 2024-11-15 Exercise | 2024-11-18 06:00 am | N/A 2032-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles Ch. Operating & Financial Off. | 25,000 | $0 | 672,458 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:31 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Director 10% Owner | 23,000 | $0 | 9,049,293 (Indirect) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-06-14 Option Award | 2024-06-18 5:00 pm | N/A 2034-06-14 | Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-28 5:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 9,460 | $4.87 | 216,664 (Direct) | View |
| 2024-05-24 Exercise | 2024-05-28 5:00 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 9,460 | $0 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $4.87 | 216,664 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-20 5:30 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 13,700 | $0 | 216,664 (Direct) | View |
| 2024-03-05 Other | 2024-03-06 5:36 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 866,979 | $0 | 1,252,944 (Indirect) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 195,000 | $0 | 195,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 5:30 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 304,500 | $0 | 304,500 (Direct) | View |